Transporters in drug development: advancing on the Critical Path

Nat Rev Drug Discov. 2010 Mar;9(3):175-6. doi: 10.1038/nrd3124.

Authors

Shiew-Mei Huang¹, Janet Woodcock

Affiliation

¹ Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, Maryland 20993-0002, USA.

PMID: 20222180
DOI: 10.1038/nrd3124

No abstract available

Publication types

Comment

MeSH terms

Drug Discovery / methods*
Drug Interactions
Drug-Related Side Effects and Adverse Reactions
Humans
Inactivation, Metabolic
Membrane Transport Proteins / drug effects*
Membrane Transport Proteins / genetics
Polymorphism, Genetic
United States
United States Food and Drug Administration

Substances

Membrane Transport Proteins